Synsorb Biotech | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Synsorb Biotech

An SI Board Since March 1996

Posts	SubjectMarks	Bans
32	0	0

Emcee: Fred J Bealle	Type: Unmoderated

Introduction Compact

This stock trades on the Alberta Stock Exchange (that is somewhere North of
Montana I think :-) as SYB. The company is HQd in Calgary AB, and has been
around for a few years. Not fly by night.
The company is developing several products to treat fatal forms of
diarrhoea. IE CALGARY, March 12 /CNW/ - SYNSORB Biotech Inc. (SBI, the
Corporation) announces that it has completed its Phase II/III
clinical trial in Canada for the treatment of patients with
hemorraghic colitis, commonly known as ``Hamburger Disease''. ...further
details are in www.newswire.ca
The corporation is not yet profitable. Trading around $3, it now spends
about $2.5 million per year in research. On Jan 16 1996, SBI was awarded
US patent 5484773 in regard to its invention, Synsorb. The chap I talked to
at Synsorb Biotech cautiously indicated it may become profitable in early 1997.
So this is an investment, not a day trade. Check out the chart.
Suggest what it might be worth in 1997 if it is better than Dr. Fowler's
remedy, Kaopectate, etc. And consider that it treats diarrhoea that is fatal,
and cannot be treated by Vancomycin (a $300 per day antibiotic.)
Is $10 to $30 in late 1997 unreasonable?

Share your expertise!
Fred Bealle
Toronto

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
32	NEWS RELEASE: Synsorb Biotech Inc - News Release Second US patent for Synsor	The Count	-	6/5/1997
31	Well Fred, I've been meaning to tell you this before, so here goes: My las	The Count	-	5/16/1997
30	Vincent, you dog! I was at that same meeting. Were you that handsome chap in a	Fred J Bealle	-	5/16/1997
29	Bloody Diarhea - ain't it great, eh! Well today was the annual meeting at	The Count	-	5/15/1997
28	Synsorb has the patent! Sell your house! Sell your dog! Buy syb. Well, maybe.	Fred J Bealle	-	4/22/1997
27	David, & all -- Oxbow may be silent, but the Globe & Mail trumpets on.	Fred J Bealle	-	4/14/1997
26	I do not beleive that the fundamentals have changed. The one player in this g	David Zabrocki	-	4/2/1997
25	Anyone out there: the fundamental haven't changed, ...right!? I keep telli	The Count	-	4/1/1997
24	Eh (i AM cdn) Fred and all others, check out this very similar recent post on t	The Count	-	3/25/1997
23	Literature: off the Synsorb topic. Book review! --------beginning of incoheren	Fred J Bealle	-	3/25/1997
22	Vincent, they are simply cooperating, and certainly have access to the same inf	Fred J Bealle	-	3/25/1997
21	Well, I know Yorkton is expecially involved with Synsorb. In the package I rec	The Count	-	3/7/1997
20	Excuse this late posting of STockwatch news on Syb; $700 000 from nserc. I des	Fred J Bealle	-	3/7/1997
19	Vincent, Stockwatch lets you see the trades, with trader subscription. The Mar	Fred J Bealle	-	3/7/1997
18	Yesterday (Mar5), the price was brought, I think, conveniently down to 9.95 ...	The Count	-	3/6/1997
17	To all; Altamira Special Growth has 136 or so stocks in small cap range, in the	Fred J Bealle	-	2/27/1997
16	Michael, Ph I & II ? You mean CDAD, of course. PK is in phase III. See ww	Fred J Bealle	-	2/11/1997
15	Whats the latest on this companies products? I've heard phase 1 and 2 tria	michael a. rowe	-	2/8/1997
14	David, the FDA rules are described in www.centerwatch.com/backgrnd.htm. Merger	Fred J Bealle	-	2/7/1997
13	David, Synsorb would be a very attractive takeover target. I would recommend bu	Fred J Bealle	-	1/27/1997
12	Thank you for the update Fred. Do you know of a good source of information on	David Zabrocki	-	1/27/1997
11	Press release: phase 1 to commence in Canada. Approval received to conduct SYN	Fred J Bealle	-	1/20/1997
10	David, thanks for answering Bruce's query on shares issued & outstandin	Fred J Bealle	-	1/16/1997
9	Hi I am glad to see that there are a few people following this company. I al	David Zabrocki	-	1/14/1997
8	Fred: Thanks for your reply, sorry, I didn't respond sooner, but I have be	Bruce Mayo	-	12/13/1996

Go to reply# or date (mm/dd/yy):